What is the relevance of quality of life assessment for patients with attention impairment?

Health and Quality of Life Outcomes

Volumn 11, Issue 1, 2013, Pages

  Baumstarck, Karine ^a   Boucekine, Mohamed ^a   Klemina, Irina ^b   Reuter, Françoise ^b   Aghababian, Valérie ^c   Loundou, Anderson ^a   Pelletier, Jean ^b   Auquier, Pascal ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

^b TIMONE HOSPITAL   (France)

^c University of Provence Aix Marseille University   (France)

Author keywords

Attention dysfunction; Multiple sclerosis; MusiQoL; Quality of life; Reliability; Validity

Indexed keywords

ADULT; ARTICLE; ATTENTION DISTURBANCE; CROSS-SECTIONAL STUDY; EXTERNAL VALIDITY; FEMALE; HUMAN; INTERNAL VALIDITY; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; QUALITY OF LIFE; RELIABILITY; VALIDATION STUDY;

CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MULTIPLE SCLEROSIS; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); QUALITY OF LIFE; QUESTIONNAIRES;

EID: 84876979936     PISSN: None     EISSN: 14777525     Source Type: Journal    
DOI: 10.1186/1477-7525-11-70     Document Type: Article

References (28)

1. Riemsma RP, Forbes CA, Glanville JM, Eastwood AJ, Kleijnen J. General health status measures for people with cognitive impairment: learning disability and acquired brain injury. Health Technol Assess 2001, 5(6):1-100.
2. Goverover Y, Chiaravalloti N, DeLuca J. The relationship between self-awareness of neurobehavioral symptoms, cognitive functioning, and emotional symptoms in multiple sclerosis. Mult Scler 2005, 11(2):203-212. 10.1191/1352458505ms1153oa, 15794396.
3. Benedict RH, Cox D, Thompson LL, Foley F, Weinstock-Guttman B, Munschauer F. Reliable screening for neuropsychological impairment in multiple sclerosis. Mult Scler 2004, 10(6):675-678. 10.1191/1352458504ms1098oa, 15584493.
4. Gold SM, Schulz H, Monch A, Schulz KH, Heesen C. Cognitive impairment in multiple sclerosis does not affect reliability and validity of self-report health measures. Mult Scler 2003, 9(4):404-410. 10.1191/1352458503ms927oa, 12926847.
5. Marrie RA, Miller DM, Chelune GJ, Cohen JA. Validity and reliability of the MSQLI in cognitively impaired patients with multiple sclerosis. Mult Scler 2003, 9(6):621-626. 10.1191/1352458503ms971oa, 14664477.
6. Baumstarck K, Pelletier J, Aghababian V, Reuter F, Klemina I, Berbis J, Loundou A, Auquier P. Is the concept of quality of life relevant for multiple sclerosis patients with cognitive impairment? Preliminary results of a cross-sectional study. PLoS One 2012, 7(1):e30627. 10.1371/journal.pone.0030627, 3264575, 22292002.
7. Baumstarck K, Reuter F, Boucekine M, Aghababian V, Klemina I, Loundou A, Pelletier J, Auquier P. Relevance of quality of life assessment for multiple sclerosis patients with memory impairment. PLoS One 2012, 7(12):e50056. 10.1371/journal.pone.0050056, 3519834, 23239975.
8. De Sonneville LM, Boringa JB, Reuling IE, Lazeron RH, Ader HJ, Polman CH. Information processing characteristics in subtypes of multiple sclerosis. Neuropsychologia 2002, 40(11):1751-1765. 10.1016/S0028-3932(02)00041-6, 12062887.
9. McCarthy M, Beaumont JG, Thompson R, Peacock S. Modality-specific aspects of sustained and divided attentional performance in multiple sclerosis. Arch Clin Neuropsychol 2005, 20(6):705-718. 10.1016/j.acn.2005.04.007, 15913949.
10. Krupp LB, Sliwinski M, Masur DM, Friedberg F, Coyle PK. Cognitive functioning and depression in patients with chronic fatigue syndrome and multiple sclerosis. Arch Neurol 1994, 51(7):705-710. 10.1001/archneur.1994.00540190089021, 8018045.
11. Zakzanis KK. Distinct neurocognitive profiles in multiple sclerosis subtypes. Arch Clin Neuropsychol 2000, 15(2):115-136.
12. Feuillet L, Reuter F, Audoin B, Malikova I, Barrau K, Cherif AA, Pelletier J. Early cognitive impairment in patients with clinically isolated syndrome suggestive of multiple sclerosis. Mult Scler 2007, 13(1):124-127. 10.1177/1352458506071196, 17294621.
13. Polman CH, Wolinsky JS, Reingold SC. Multiple sclerosis diagnostic criteria: three years later. Mult Scler 2005, 11(1):5-12. 10.1191/1352458505ms1135oa, 15732260.
14. Leplege A, Ecosse E, Verdier A, Perneger TV. The French SF-36 health survey: translation, cultural adaptation and preliminary psychometric evaluation. J Clin Epidemiol 1998, 51(11):1013-1023. 10.1016/S0895-4356(98)00093-6, 9817119.
15. Gronwall DM. Paced auditory serial-addition task: a measure of recovery from concussion. Percept Mot Skills 1977, 44(2):367-373. 10.2466/pms.1977.44.2.367, 866038.
16. Wechsler D. WMS-R Echelle clinique de Mémoire de Wechsler-Révisée 1991, Paris: Les Editions du Centre de Psychologie Appliquée.
17. Reuter F, Baumstarck-Barrau K, Loundou A, Pelletier J, Auquier P. Paced auditory serial addition test: normative data in a French population. Rev Neurol (Paris) 2010, 166(11):944-947.
18. Simeoni MC, Auquier P, Fernandez O, Flachenecker P, Stecchi S, Constantinescu C, Idiman E, Boyko A, Beiske A, Vollmer T. Validation of the multiple sclerosis international quality of life questionnaire. Mult Scler 2008, 14(2):219-230.
19. Juniper EF, Guyatt GH, Mesbah M, Ravaud P. Quality of life and pharmacoeconomics in clinical trials 1996, Philadelphia: Lippincott-Raven.
20. Nunnaly JC, Bernstein IC. Psychometric theory 1994, New York: Mc Graw-Hill.
21. Ware JE, Harris WJ, Gandek B, Rogers BW. MAP-R for windows: Multitrait-multi-item analysis program - revised User's guide 1997, Boston: Health Assessment Lab.
22. Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika 1951, 16:297-334.
23. Wright BD, Stone MH. Best test design: Rasch measurement 1979, Chicago: Mesa press.
24. Marrie RA, Goldman M. Validity of performance scales for disability assessment in multiple sclerosis. Mult Scler 2007, 13(9):1176-1182. 10.1177/1352458507078388, 17623733.
25. Achiron A, Barak Y. Cognitive changes in early MS: a call for a common framework. J Neurol Sci 2006, 245(1-2):47-51.
26. Arnett PA, Randolph JJ. Longitudinal course of depression symptoms in multiple sclerosis. J Neurol Neurosurg Psychiatry 2006, 77(5):606-610. 10.1136/jnnp.2004.047712, 2117462, 16614019.
27. Debouverie M, Pittion-Vouyovitch S, Brissart H, Guillemin F. Physical dimension of fatigue correlated with disability change over time in patients with multiple sclerosis. J Neurol 2008, 255(5):633-636. 10.1007/s00415-008-0761-6, 18217185.
28. Oken BS, Flegal K, Zajdel D, Kishiyama SS, Lovera J, Bagert B, Bourdette DN. Cognition and fatigue in multiple sclerosis: potential effects of medications with central nervous system activity. J Rehabil Res Dev 2006, 43(1):83-90. 10.1682/JRRD.2004.11.0148, 16847774.